0000950170-24-068803.txt : 20240604
0000950170-24-068803.hdr.sgml : 20240604
20240604170003
ACCESSION NUMBER: 0000950170-24-068803
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240601
FILED AS OF DATE: 20240604
DATE AS OF CHANGE: 20240604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moore Mary Ann E
CENTRAL INDEX KEY: 0001894731
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12111
FILM NUMBER: 241019120
MAIL ADDRESS:
STREET 1: 1301 CONCORD TERRACE
CITY: SUNRISE
STATE: FL
ZIP: 33323
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pediatrix Medical Group, Inc.
CENTRAL INDEX KEY: 0000893949
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 263667538
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1301 CONCORD TERRACE
CITY: SUNRISE
STATE: FL
ZIP: 33323
BUSINESS PHONE: 9543840175
MAIL ADDRESS:
STREET 1: 1301 CONCORD TERRACE
CITY: SUNRISE
STATE: FL
ZIP: 33323
FORMER COMPANY:
FORMER CONFORMED NAME: MEDNAX, INC.
DATE OF NAME CHANGE: 20090102
FORMER COMPANY:
FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC
DATE OF NAME CHANGE: 19950801
4
1
ownership.xml
4
X0508
4
2024-06-01
0000893949
Pediatrix Medical Group, Inc.
MD
0001894731
Moore Mary Ann E
1301 CONCORD TERRACE
SUNRISE
FL
33323
false
true
false
false
EVP, General Counsel & Sec
false
Common Stock
2024-06-01
4
A
false
68400
0
A
143918
D
Common Stock
15730
I
By Trust
Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2025, twenty-five percent (25%) of the restricted shares will vest on June 1, 2026 and fifty percent (50%) of the restricted shares will vest on June 1, 2027, subject to the terms of the Plan.
The reporting person and her spouse are trustees of the trust that holds the reported securities. The reporting person disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein.
Mary Ann E. Moore
2024-06-04